The MFS-type efflux pump Flr1 induced by Yap1 promotes canthin-6-one resistance in yeast

Camille Dejos1, Matthieu Régnacq, Marianne Bernard

  • 1Institut de Physiologie et Biologie Cellulaires, CNRS FRE 3511, Université de Poitiers, Poitiers, France.

FEBS Letters
|August 6, 2013
PubMed

Insights

Researchers found that Yap1, a key transcription factor, enhances resistance to canthin-6-one toxicity in yeast. This Yap1-mediated drug resistance primarily involves the Flr1 efflux pump, not Ycf1.

Area of Science:

  • Molecular Biology
  • Yeast Genetics
  • Drug Resistance Mechanisms

Background:

  • Canthin-6-one is a compound with known toxicity.
  • Yeast (Saccharomyces cerevisiae) is a model organism for studying cellular responses.
  • Transcription factors play crucial roles in regulating gene expression and cellular defense.

Purpose of the Study:

  • To identify genetic suppressors of canthin-6-one toxicity in yeast.
  • To elucidate the molecular mechanisms underlying Yap1-mediated resistance to canthin-6-one.
  • To investigate the roles of specific efflux pumps in drug resistance.

Main Methods:

  • Yeast screening to identify suppressors of canthin-6-one toxicity.
  • Gene overexpression studies (YAP1 and FLR1).
  • Analysis of drug sensitivity and resistance phenotypes.
  • Investigating the involvement of specific transporters (Flr1 and Ycf1).

Main Results:

  • Yap1, a transcription factor, was identified as a suppressor of canthin-6-one toxicity.
  • Overexpression of YAP1 significantly increased resistance to canthin-6-one.
  • Yap1-mediated resistance was dependent on the major facilitator superfamily efflux pump Flr1.
  • The vacuolar transporter Ycf1 was not involved in this resistance mechanism.
  • FLR1 overexpression conferred resistance, but only in the presence of functional YAP1.

Conclusions:

  • Yap1 confers resistance to canthin-6-one toxicity in yeast.
  • This resistance is primarily mediated by the plasma membrane efflux pump Flr1.
  • The findings highlight the role of Yap1 and Flr1 in cellular defense against specific toxic compounds.